Review
Copyright ©The Author(s) 2021.
World J Gastrointest Endosc. Aug 16, 2021; 13(8): 275-295
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.275
Table 1 Diagnostic performance for the histological prediction of underlying malignancy of colorectal lesions according to their morphological pattern as well as to Kudo pit pattern, narrow-band imaging international colorectal endoscopic, and Japan narrow-band imaging expert team classifications
Variables
Sensitivity
Specificity
PPV
NPV
Accuracy
Morphological pattern1
0-IIa G5.7% 70.0%1.7% 89.1% 64.6%
0-Is G 11.5%83.2% 5.8% 91.2% 77.3%
0-IIa + Is G 22.9% 77.4% 8.4% 91.7%72.8%
0-IIa NG 27.4% 79.5%10.8% 92.4% 75.2%
0-Is NG 16.6% 95.5% 25.0%92.7% 89.0%
0-IIa + Is NG 15.9% 94.5% 20.7% 92.6% 88.0%
Kudo pit pattern (NBI)273.3%-93.7%389.2%-100%393.7%-100%3 89.2%-96.4%392.0%-96.7%3
NICE classification4
Type 182.1%-84.6%93.8%-94.9%65.9%-92.5%60.4-98.2%93.9%-97.8%
Type 2 89.8%-91.4%84.3%-86.3%89.1%-90.7%97.3-97.7%56.6%-61.2%
Type 3 83.3%-91.7%96.4%-97.0%96.0%-96.8%45.8-54.0%99.4%-99.7%
JNET classification5
Type 173.0%-87.1%96.0%-99.5%73.4%-92.3%96%-98.9%93.0%-98.5%
Type 2A82.5%-96.0%70.0%-91.1%90.3%-96.7%62.1%-92.1%84.5%-90.9%
Type 2B42.0%-75.6%84.2%-95.0%26.0%-67.3%92.2%-98.0%81.3%-93.0%
Type 335.0%-91.7%98.1%-100%63.2%-100%93.8%-99.7%94.0%-98.0%
Table 2 Characteristics of the seven included systematic reviews and meta-analyses on the comparison between the outcomes for endoscopic mucosal resection and endoscopic submucosal dissection procedures
Ref.
Study
Nations
N patients/lesions
Type of colorectal lesions
Lesion size
Procedural time1
En bloc resection1
R01
Perforation1
Bleeding1
Surgery1
Recurrence1
Zhong et al[134], 2013Systematic review with meta-analysis of 4 retrospective studiesJapan, Korea, China243 patients/245 lesions (EMR: 106; ESD: 139)Sessile (carcinoids)< 15 mm19.1 ± 11.1 vs 8.1 ± 9.492% vs 100%69.1% vs 87.7%2.8% vs 0.7%2.8% vs 3.6%0.7% vs 0%2.9% vs 0%
Wang et al[135], 2014Meta-analysis of 6 studies (case-control)Japan, Korea893 patients/1642 lesions (EMR: 866; ESD: 776)Sessile or flat ≥ 10 mmRange, 29.0-29.4 vs 87.2-108.0 min44.5% vs 87.9%65.5% vs 83.8%5.8% vs 8.9% (overall complications) NA12.70% vs 0.98%
Wang et al[136], 2016Systematic review with meta-analysis of 4 retrospective studiesBrazil, Korea, Japan, China216 patients/216 lesions (EMR: 109; ESD: 107)Rectal carcinoids (lesion morphology not specified)≥ 10 mm(150.0 ± 66.3/116.0 ± 58.5 ± 3.6/63.0 ± 54.0/50.0 ± 589.2) vs (133.0 ± 94.8/84.0 ± 51.2/131.0 ± 100.0/78 ± 176.7) min93.6% vs 90.6%78% vs 79.4%10.3% vs 18.3% (overall complications) NA6.4% vs 0.9%
Chao et al[137], 2016Meta-analysis of 17 studies (retrospective)China2003 patients/2003 lesions (EMR: 1054; ESD: 949)Sessile: carcinoids (11 studies) or carcinomas (5 studies); LST (1 study)≥ 5 mmRange, 15.0-65.9 vs 3.5-29.4 min89.8% vs 92.0%61.4% vs 86.5%1.5% vs 5.9 %3.3% vs 3.7%NA9.9% vs 1.0%
Fujiya et al[103], 2015Meta-analysis of 8 studies (non-randomized, 6 cohort and 2 case-control)Japan1262 patients (EMR: 634; ESD: 628)/1763 lesions (EMR: 949; ESD: 814)Morphological features of lesions in 7 studies were2, in the EMR group: 0-I (269 cases) and 0-II (679 cases); in the ESD group: 0-I (125 cases) and 0-II (680 cases); 576 adenomas and 380 carcinomas≥ 20 mm (5 studies), ≥ 10 mm (1 study), > 5 mm (1 study)Range, 29.0-30.0 vs 65.9-108.0 min46.7% vs 91.7% 42.3% vs 80.3% 0% vs 8.5%3.5% vs 2.0%5.8% vs 9.9%12.2% vs 0.9%
Arezzo et al[138], 2016Systematic review with meta-analysis of 11 studies (10 retrospective and 1 case-control)Japan, Korea, France4678 patients/4678 lesions (EMR: 3161; ESD: 1517)Sessile (LST-NG and LST-G were also included in 3 studies): adenomas, carcinomas in situ, invasive cancers or carcinoids≥ 20 mm (except in 3 studies)29.1 vs 66.5 min34.9% vs 89.9% 36.2% vs 79.6%0.9% vs 4.9%2.9% vs 1.9%3.0% vs 7.8% 12.7% vs 0.7%
De Ceglie et al[107], 2016Systematic review of 66 studies (3 RCTs; 22 prospective and 41 retrospective)Germany, Taiwan, France, Japan, Greece, Great Britain, Czech Republic, Malaysia, Australia, Italy, China, United States, Brazil, Korea, Portugal, Serbia13659 patients (EMR: 8660; ESD: 4999)/17950 lesions (EMR: 11.873; ESD: 6077)Sessile or LSTLST-NG ≥ 20 mm and for LST-G ≥ 30 mm or ≥ 40 mmNA62.8% vs 90.5% 92.0% vs 82.1%0.9% vs 4.8%2.3% vs 2.0%NA10.4% (3.0% in en bloc and 12% in piecemeal) vs 1.2%